EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

…, E Mysler, P Nash, K Pavelka, G Poór… - Annals of the …, 2017 - ard.bmj.com
… in patients with high disease activity,151 the evidence for increased overall and cardiovascular
mortality at a dose above a threshold of 7.5 mg/day or a cumulative dose of 40 g is …

[HTML][HTML] Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) initiative

…, Y Ozyazgan, F Pablo, MP Paroli, U Pleyer, G Poór… - Ophthalmology, 2018 - Elsevier
Topic An international, expert-led consensus initiative to develop systematic, evidence-based
recommendations for the treatment of noninfectious uveitis in the era of biologics. Clinical …

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

…, EF Mysler, JAP Da Silva, G Poór… - Annals of the …, 2020 - ard.bmj.com
Objectives To provide an update of the European League Against Rheumatism (EULAR)
rheumatoid arthritis (RA) management recommendations to account for the most recent …

Relapsing polychondritis

P Gergely Jr, G Poór - Best Practice & Research Clinical Rheumatology, 2004 - Elsevier
Relapsing polychondritis (RP) is a rare multisystem autoimmune disease of unknown origin
characterized by recurrent episodes of inflammation and progressive destruction of …

2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative …

…, C Duftner, HS Jensen, P Duhaut, G Poór… - Arthritis & …, 2012 - Wiley Online Library
The objective of this study was to develop European League Against Rheumatism/American
College of Rheumatology classification criteria for polymyalgia rheumatica (PMR). …

Determinants of reduced survival following hip fractures in men.

G Poór, EJ Atkinson, WM O'Fallon… - … and Related Research …, 1995 - journals.lww.com
… In contrast to the findings of others,*g there was no strong correlation of age with comorbidity
in this population. Activity status before fracture, mental confusion during hospitalization, …

Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis

L Bucsi, G Poór - Osteoarthritis and Cartilage, 1998 - Elsevier
Patients with osteoarthritis (OA) of the knee were treated with chondroitin sulfate (CS,
Condrosulf R , IBSA, Lugano, CH) in a randomized, double-blind, placebo-controlled study, …

Epidemiology of Paget's disease in Europe: the prevalence is decreasing

G Poór, J Donáth, B Fornet… - Journal of bone and …, 2006 - academic.oup.com
This study estimated changes in the age‐ and sex‐specific prevalence of Paget's disease of
bone in six European towns over a 20‐year period. Declines in prevalence were observed …

Predictors of hip fractures in elderly men

G Poór, EJ Atkinson, WM O'Fallon… - Journal of Bone and …, 2020 - academic.oup.com
To assess the influence on the risk of hip fractures in men of medical conditions associated
with secondary osteoporosis or with an increased likelihood of falling, we conducted a …

Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples

…, C Sipeky, IF Horváth, M Zeher, G Poór… - Scandinavian …, 2009 - Wiley Online Library
Recently, associations were found between several autoimmune diseases and functional
variants of interleukin‐23 receptor (IL23R) gene; here, we studied the possible association of …